NEW YORK (GenomeWeb) – Cytox said today that it has raised £2.6 million ($3.3 million) in new financing. The British genetics company will use the proceeds to support the roll out of its Alzheimer's disease testing service.

GM&C Life Sciences Fund — a Manchester, UK-based seed and early stage venture capital fund managed by Catapult Ventures — led the round as a new investor. Existing investors Perivoli Innovations, the Rainbow Seed Fund, the University of Oxford, and other private investors also contributed.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Researchers describe a way to share data while keeping it secure, Agence France Presse reports.

In Science this week: genetic mutations typically associated with esophageal cancer are common in older, healthy individuals, and more.

India's Council of Scientific and Industrial Research has a new director-general, according to ScienceInsider.

A new study links more than a hundred genes to autism spectrum disorder, Discover's D-brief blog reports.